Inventor · disambiguated record
Shmuel Ben-Sasson
Also filed as: BEN-SASSON SHMUEL · BEN-SASSON SHMUEL A
21 granted patents·29 pending applications·315 citations·filing 1985–2021
95Inventor score
Files withCHILDRENS MEDICAL CENTER15BEN-SASSON SHMUEL A5CHIASMA INC5YISSUM RES DEV CO OF HEBREW UNIV JERUSALEM LTD5RAZIEL THERAPEUTICS LTD3
Top patents by PatentIndex Score
50 records- 0195US8241670B2Compositions capable of facilitating penetration across a biological barrierBEN-SASSON SHMUEL A·Filed 2005·Granted Aug 14, 2012·95 cites·22 claims
- 0288US6235716B1Multivalent ligands which modulate angiogenesisCHILDRENS MEDICAL CENTER·Filed 1999·Granted May 22, 2001·72 cites·60 claims
- 0386US6121236AMultivalent ligands which modulate angiogenesisCHILDRENS MEDICAL CENTER·Filed 1998·Granted Sep 19, 2000·47 cites·13 claims
- 0485US10632102B2Carbazole derivatives for the treatment of fibrotic diseases and related symptoms, and conditions thereofRAZIEL THERAPEUTICS LTD·Filed 2016·Granted Apr 28, 2020·2 cites·16 claims
- 0585US7115707B2Amino acid sequences capable of facilitating penetration across a biological barrierCHIASMA INC·Filed 2003·Granted Oct 3, 2006·29 cites·40 claims
- 0684US6723830B2Short peptides which selectively modulate the activity of protein kinasesCHILDRENS MEDICAL CENTER·Filed 2002·Granted Apr 20, 2004·17 cites·34 claims
- 0782US11191748B2Carbazole derivatives for the treatment of fibrotic diseases and related symptoms, and conditions thereofRAZIEL THERAPEUTICS LTD·Filed 2020·Granted Dec 7, 2021·1 cites·14 claims
- 0881US6770626B2Tissue remodelingCHILDRENS MEDICAL CENTER·Filed 2001·Granted Aug 3, 2004·11 cites·2 claims
- 0976US7683031B2Short peptides from the ‘2nd loop’ of 7 transmembrane receptor which selectively modulate signal transductionYISSUM RES DEV CO·Filed 2003·Granted Mar 23, 2010·4 cites·16 claims
- 1075US7838513B2Anti-cancer therapy comprising an H2-blocker, at least one antiinflammatory agent and a cytotoxic agentTILTAN PHARMA LTD·Filed 2007·Granted Nov 23, 2010·1 cites·26 claims
- 1173US12097179B2Carbazole derivatives for the treatment of fibrotic diseases and related symptoms, and conditions thereofRAZIEL THERAPEUTICS LTD·Filed 2021·Granted Sep 24, 2024·0 cites·10 claims
- 1269US2010071095A1Method for Generating Plant Diversity By Incorporation of Microsatellite Sequences Into the Plant GenomeBAHIR IRIS·Filed 2009·Application pending·0 cites
- 1368US7037891B2Methods of modulating G-protein-coupled receptor kinase-associated signal transductionYISSUM RES AND DEV·Filed 2001·Granted May 2, 2006·3 cites·29 claims
- 1467US9447040B2Tricyclic compounds, compositions comprising them and uses thereofYISSUM RES DEV CO·Filed 2012·Granted Sep 20, 2016·2 cites·20 claims
- 1567US2016030568A1Compositions capable of facilitating penetration across a biological barrierCHIASMA INC·Filed 2014·Application pending·0 cites
- 1665US6833436B2Short peptides which selectively modulate the activity of serine/threonine kinasesCHILDRENS MEDICAL CENTER·Filed 2000·Granted Dec 21, 2004·2 cites·1 claims
- 1764US2007219131A1Compositions capable of facilitating penetration across a biological barrierBEN-SASSON SHMUEL A·Filed 2006·Application pending·0 cites
- 1862US2007275055A1Compositions capable of facilitating penetration across a biological barrierCHIASMA INC·Filed 2007·Application pending·0 cites
- 1959US6174993B1Short peptides which selectively modulate the activity of serine/threonine kinasesCHILDRENS MEDICAL CENTER·Filed 1997·Granted Jan 16, 2001·14 cites·9 claims
- 2059US2006265775A1Method for generating plant diversity by incorporation of microsatellite sequences into the plant genomeBAHIR IRIS·Filed 2004·Application pending·0 cites
- 2159US2017106089A1Compositions capable of facilitating penetration across a biological barrierCHIASMA INC·Filed 2016·Application pending·0 cites
- 2258US2008045460A1Treatment of prostate cancer by inhibiting lyn-tyrosine kinaseCHILDRENS MEDICAL CENTER·Filed 2006·Application pending·0 cites
- 2356US2004254116A1Tissue remodelingCHILDRENS MEDICAL CENTER·Filed 2004·Application pending·0 cites
- 2455US9770454B2IGF-1R signaling pathway inhibitors useful in the treatment of neurodegenerative diseasesYISSUM RES DEV CO·Filed 2014·Granted Sep 26, 2017·0 cites·12 claims
- 2555US2023338322A1Glyceryltriacetate (gta) for use in improving breathingYISSUM RES DEV CO OF HEBREW UNIV JERUSALEM LTD·Filed 2021·Application pending·0 cites
- 2654US10188659B2IGF-1R signaling pathway inhibitors useful in the treatment of neurodegenerative diseasesYISSUM RES DEV CO OF HEBREW UNIV JERUSALEM LTD·Filed 2017·Granted Jan 29, 2019·0 cites·11 claims
- 2754US2005058702A1Compositions capable of facilitating penetration across a biological barrierFiled 2003·Application pending·0 cites
- 2853US2002137141A1Short peptides from the 'A-region' of protein kinases which selectively modulate protein kinase activityCHILDRENS MEDICAL CENTER·Filed 2001·Application pending·0 cites
- 2951US2005136103A1Compositions capable of facilitating penetration across a biological barrierFiled 2004·Application pending·0 cites
- 3050US6723694B1Short peptides which selectively modulate intracellular signallingCHILDRENS MEDICAL CENTER·Filed 1997·Granted Apr 20, 2004·9 cites·87 claims
- 3150US2002115173A1Short peptides from the 'A-region' of protein kinases which selectively modulate protein kinase activityCHILDRENS MEDICAL CENTER·Filed 2000·Application pending·0 cites
- 3250US2002151497A1Treatment of prostate cancer by inhibiting Lyn tyrosine kinaseCHILDRENS MEDICAL CENTER·Filed 2001·Application pending·0 cites
- 3349US2006251713A1Amino acid sequences capable of facilitating penetration across a biological barrierCHIASMA INC·Filed 2006·Application pending·0 cites
- 3449US2004121952A1Treatment of cancerCHILDRENS MEDICAL CENTER·Filed 2003·Application pending·0 cites
- 3548US9873724B2Pro-angiogenic peptides and peptide conjugatesYISSUM RES DEV CO OF HEBREW UNIV JERUSALEM LTD·Filed 2014·Granted Jan 23, 2018·0 cites·14 claims
- 3648US2002019346A1Treatment of prostate cancer by inhibiting lyn tyrosine kinaseCHILDRENS MEDICAL CENTER·Filed 2000·Application pending·0 cites
- 3746US2021253511A1Compounds and uses for the treatment and prevention of diseases and conditions associate with or aggrevated by impared mitophagyYISSUM RES DEV CO OF HEBREW UNIV JERUSALEM LTD·Filed 2019·Application pending·0 cites
- 3846US2003211589A1Short peptides from the b4 and b5 regions kinases which selectively modulate protein activityFiled 2000·Application pending·0 cites
- 3946US2013157939A1Compositions for gastric delivery of active agentsBEN-SASSON SHMUEL·Filed 2011·Application pending·0 cites
- 4045US2005215478A1Amino acid sequences capable of facilitating penetration across a biological barrierBEN-SASSON SHMUEL A·Filed 2003·Application pending·0 cites
- 4145US2011071100A1Sulfobetaines for cancer, obesity, macular degeneration, neurodegenerative diseasesTILTAN PHARMA LTD·Filed 2009·Application pending·0 cites
- 4245US2021171604A1Peptides for the treatment of type 2 diabetesYISSUM RES DEV CO OF HEBREW UNIV JERUSALEM LTD·Filed 2018·Application pending·0 cites
- 4345US2007172517A1Compositions capable of facilitation penetration across a biological barrierBEN-SASSON SHMUEL A·Filed 2004·Application pending·0 cites
- 4442US2022000805A1Combination of m-opioid receptor (mor) modulators for preventing and treating pain, suicidality and mental disordersHADAS IT MEDICAL RES SERVICES & DEVELOPMENT LIMITED·Filed 2019·Application pending·0 cites
- 4541US2005148521A1Anti-cancer combination and use thereofCHILDRENS MEDICAL CENTER·Filed 2004·Application pending·0 cites
- 4640US2009010887A1Method and composition for enhancing anti-angiogenic therapyBEN-SASSON SHMUEL A·Filed 2005·Application pending·0 cites
- 4739US2002028772A1Modulators of activity of G-protein-coupled receptor kinasesCHILDREN S MED CORP·Filed 2000·Application pending·0 cites
- 4838US4780307AAluminum hydroxideRAFA LABOR LTD·Filed 1985·Granted Oct 25, 1988·4 cites·15 claims
- 4936US2015005252A1Combination therapy for the treatment of cancerTILTAN PHARMA LTD·Filed 2013·Application pending·0 cites
- 5027US4840795APreparation and method for effecting fat and lipid adsorptionRAFA LAB·Filed 1987·Granted Jun 20, 1989·2 cites·15 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →